Wong Pak Chiu, She Wong Hoi, Khoo Ui Soon, Cheung Tan To
Department of Surgery, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China.
Department of Pathology, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China.
Case Rep Oncol. 2021 Feb 25;14(1):90-97. doi: 10.1159/000510935. eCollection 2021 Jan-Apr.
We report an unusual presentation of primary hepatic neuroendocrine tumor which was initially misdiagnosed as intrahepatic cholangiocarcinoma. The diagnosis was only revealed after a major liver resection by histopathology. With adjuvant lanreotide injection, the patient survived for more than 16 months after the operation without tumor recurrence. Diagnosis of this rare tumor has been a major challenge and we emphasize the importance of a preoperative diagnosis. Surgical resection remains the mainstay for curative treatment, while peptide receptor radionuclide therapy is an emerging treatment option which has provided promising results.
我们报告了一例原发性肝神经内分泌肿瘤的不寻常表现,该病例最初被误诊为肝内胆管癌。仅在进行大肝切除术后通过组织病理学检查才确诊。通过辅助注射兰瑞肽,患者术后存活超过16个月且无肿瘤复发。诊断这种罕见肿瘤一直是一项重大挑战,我们强调术前诊断的重要性。手术切除仍然是根治性治疗的主要手段,而肽受体放射性核素治疗是一种新兴的治疗选择,已取得了有希望的结果。